One company's quest for an antibody drug to fight COVID-19 Companies are testing drugs that mimic the way the body fights COVID-19, hoping they can fill a key gap as vaccines remain months off for most peopleOn a Saturday afternoon in March as COVID-19 was bearing down on New York City, a dozen scientists anxiously crowded around a computer in a suburban drug company’s lab. This was the start of a drug that would, eventually, go into the arms of a U.S. president and others fighting off COVID-19. Unlike chemicals that are simply mixed in a lab, antibodies are coaxed from living cells. Regeneron’s two-antibody drug is unique: One came from a COVID-19 survivor in Singapore and the other from the company’s genetically modified mice. Regeneron sells other antibody drugs for heart disease, cancer and other conditions.

Source: ABC News December 21, 2020 05:03 UTC